BRIP1 and neoplasm: This work and that of others, reviewed in (Cantor and Guillemette, 2011), emphasizes the prominent role of FANCJ as a tumor suppressor, which may be informative for future studies in personalized medicine that exploit the mutational status of FANCJ and other DNA repair helicases (see below).